NUVISAN Pharma Services Selects ALPHADAS to Accelerate Clinical Development Processes
ALPHADAS Chosen to Replace Existing System at Phase I Unit in Germany
CONSHOHOCKEN, PA - (BUSINESS WIRE) – June 11, 2014 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that NUVISAN Pharma Services (“NUVISAN”) has purchased the ALPHADAS® clinical trials software solution suite for deployment in its Phase I unit located in Neu-Ulm, Germany.
NUVISAN is a fully integrated contract research organization providing clinical development and lab services to the global pharmaceutical industry. For over 30 years, NUVISAN has been assisting their clients in bringing safe and effective pharmaceutical products to market through its complete spectrum of services and the long-standing experience of their staff.
Following a competitive evaluation of commercial software systems and vendors, NUVISAN selected Instem’s ALPHADAS software suite based on its ability to support their clinical development team’s specific needs through flexible configurations, the ability to integrate with other support systems through the unit and for Instem’s rapid deployment services.
In addition to improving processes at their Phase I unit, ALPHADAS will be integrating with NUVISAN’s central lab operations resulting in enhanced quality and consistency while simultaneously improving efficiencies and saving time.
“Following a thorough evaluation of several software solutions, and after visiting with clients of each vendor under consideration, it was clear that ALPHADAS by Instem would not only be replacing our existing system, but was the one solution that would truly be providing us with the platform we need to help our clients succeed,” comments James Dickinson, Head of NUVISAN’s Phase I unit. “In addition to the technology, Instem is a well-respected, stable organization offering NUVISAN true subject matter expertise by staff that have run Phase I labs themselves. Bringing more than just software to us was an essential driver behind our decision and we are looking forward to a quick and efficient rollout of their system.”
Instem’s ALPHADAS software solution suite is a proactive early phase eSource data capture system with comprehensive CTMS capabilities. ALPHADAS is mobile, schedule-driven, and provides real-time bedside or station based direct data capture that virtually eliminates paper-based data.
ALPHADAS is used by organizations across four continents & is proven to improve operational efficiencies, reduce trial times, enhance data quality and protocol compliance and provide real-time data to sponsors.
“It is with great pleasure that we welcome a forward-looking research organization such as Nuvisan to the ALPHADAS community,” comments Mark Cusack, VP Business Development at Instem Clinical. “Particularly pertinent is that Nuvisan is using ALPHADAS to replace their bespoke legacy system of many years. ALPHADAS is a superior system forged over years of live use and its comprehensive features coupled with true flexibility is meeting the demands of our clients for immediate efficiency gains. This is why it is at the forefront of eSource data collection and CTMS solutions.” Cusack continued, “ALPHADAS is backed by a prominent experienced implementation team that drives and invigorates process improvements and efficiencies during all of our deployments. This is what Nuvisan witnessed when they visited users of ALPHADAS and it is that track record of success by market comparison that ultimately led to their decision.”
- ALPHADAS to be deployed at a Phase I unit at NUVISAN Pharma Services, a leading CRO based in Germany to replace bespoke legacy system
- ALPHADAS solution replacing existing software system
- ALPHADAS to be integrated with NUVISAN central labs
- Nuvisan to implement entire ALPHADAS software suite
- Instem chosen for reputation in Life Sciences, stability and strong support services
About NUVISAN Pharma Services
NUVISAN Pharma Services is a global provider of product development and support services to the pharmaceutical, biotechnology and medical device industries. NUVISAN delivers services ranging from a single test to fully integrated drug development programs.
NUVISAN offers their sponsors the complete spectrum of drug development services and assist the sponsor in bringing safe and effective pharmaceutical products to market. NUVISAN tailors their services through integrated programs or stand-alone solutions and is recognized as a leading contract research organization driven by proven experience, commitment, and Technology under one organizational umbrella.
More about NUVISAN can be found at www.nuvisan.com
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600